U.S. Medicare sets outpatient rate for Yescarta reimbursement

(Reuters) – Medicare, the U.S. government healthcare program for the elderly and disabled, will pay hospitals close to its standard mark-up rate for administering cell therapy Yescarta for cancer outpatients, who will have a co-payment of nearly $80,000, according to the Centers for Medicare & Medicaid Services (CMS).

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *